ArticleParasitology research2026
RmTIL, a cysteine-rich protein as a putative microbiota modulator from Rhipicephalus microplus tick.
Article in Parasitology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhipicephalus microplus, also known as the "cattle tick", presents worldwide distribution in tropical and subtropical regions and causes significant economic losses in livestock activity. At the present work, an immunogenic cysteine-rich protein produced in salivary glands was identified through an association of phage display and third generation sequencing (TGS) high-throughput techniques. This protein presenting a trypsin inhibitor-like (TIL) domain from R. microplus, named here as RmTIL, was expressed as a recombinant protein and submitted to a functional characterization as a serine protease inhibitor. The recombinant protein corresponding to its TIL domain portion (rRmTIL-D) inhibited human neutrophil elastase, cathepsin G, and subtilisin A, displaying inhibition constant (K
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.